Managing Ulcerative Colitis: The Guidelines and Beyond - European Medical Journal

Managing Ulcerative Colitis: The Guidelines and Beyond

Gastroenterology
Download PDF
Authors:
Mitchell RKL Lie, C Janneke van der Woude
Disclosure:

No potential conflict of interest.

Received:
17.09.13
Accepted:
19.11.13
Citation:
EMJ Gastroenterol. ;[1]:82-91. DOI/10.33590/emjgastroenterol/10312665. https://doi.org/10.33590/emjgastroenterol/10312665.
Keywords:
Ulcerative colitis, management, therapy, 5-ASA, corticosteroids, azathioprine, 6-mercaptopurine, 6-thioguanine, cyclosporine, tacrolimus, methotrexate, mycophenolate mofetil, infliximab, adalimumab, golimumab, vedolizumab

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

Abstract

Management guidelines offer clinicians clear, evidence-based and often succinct treatment advice. For ulcerative colitis these guidelines describe the use of 5-ASA, corticosteroids, thiopurines, cyclosporine, and anti-TNFα therapies. However, guidelines do have some drawbacks, mainly a lack of concrete advice concerning patients resistant to these aforementioned therapies. This review gives a short overview of current guidelines and addresses treatment alternatives for conventional therapies.

Please view the full content in the pdf above.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?

Keep your finger on the pulse

Join Now

Elevating the Quality of Healthcare Globally

>